| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.7 |